Providing individualized feedback about the risk of developing cardiovascular disease to community health center patients increased treatment discussions with primary care physicians, according to a new Northwestern Medicine study.
A recent study co-authored by Northwestern Medicine scientists demonstrates the molecular mechanisms that may underlie left ventricular hypertrophy, a pattern of cardiac injury common in patients with chronic kidney disease.
Nina Gotteiner, MD, associate professor of Pediatrics in the Division of Cardiology, studied the outcomes and predictors of fetuses diagnosed with Epstein anomaly or tricuspid valve dysplasia.
Many patients on antihypertensive medications are at greater risk of cardiovascular disease, despite controlled numbers, according to a new Northwestern Medicine study.
Robert Bonow, MD, the Max and Lilly Goldberg Distinguished Professor of Cardiology, has been named editor-in-chief of JAMA Cardiology, a new journal in the JAMA Network that will debut in 2016.
In a recent study, Shuang Zhang, a fourth year student in the Driskill Graduate Program in the Life Sciences (DGP), shed light on a molecule that mediates cross-talk between cardiac cells and immune cells after injury.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
A new imaging technique that allows for visualization of blood flow in real-time revealed that abnormal blood flow from the two-flap valve in bicuspid aortic valve disease can create weakness in the aorta.
A study showed that an investigational drug, idarucizumab, reverses the anticoagulant effect of dabigatran, a blood thinning drug used for the prevention of stroke. This is the first test of this reversal agent in patients with bleeding or need for emergent surgery.